HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer | MicrobiomeTrials← Back to trialsNCT07232875
HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2025-11-21Est. Completion: 2029-04
Enrollment target: 588 participants Locations- Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China